Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARTIN E ORLICK

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1003816018
CMS profile
157
Location
ST PETERSBURG, FL

General Payments · PY2018–2024

$2,797.65

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$301.62

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $283.78 14
Education $17.84 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $485.51 16
PY2019 $542.62 20
PY2020 $44.06 2
PY2021 $451.65 13
PY2022 $437.31 17
PY2023 $534.88 28
PY2024 $301.62 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Apellis Pharmaceuticals, Inc. $26.27 02/15/2024 Food and Beverage Undisputed 01/23/2026 1154025667 CMS
Astellas Pharma US Inc $29.55 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139301410 CMS
Astellas Pharma US Inc $25.60 07/11/2024 Food and Beverage Undisputed 01/23/2026 1139374225 CMS
Bausch & Lomb Americas Inc. $17.84 01/26/2024 Education Undisputed 01/23/2026 1140405060 CMS
Bausch & Lomb Americas Inc. $18.14 05/13/2024 Food and Beverage Undisputed 01/23/2026 1140405062 CMS
Mallinckrodt Hospital Products Inc. $35.02 03/14/2024 Food and Beverage Undisputed 01/23/2026 1145115304 CMS
Mallinckrodt Hospital Products Inc. $1.68 03/14/2024 Food and Beverage Undisputed 01/23/2026 1145115308 CMS
Mallinckrodt Hospital Products Inc. $0.54 04/18/2024 Food and Beverage Undisputed 01/23/2026 1145115312 CMS
Mallinckrodt Hospital Products Inc. $37.60 04/18/2024 Food and Beverage Undisputed 01/23/2026 1145115316 CMS
Mallinckrodt Hospital Products Inc. $0.80 05/16/2024 Food and Beverage Undisputed 01/23/2026 1145115320 CMS
Mallinckrodt Hospital Products Inc. $26.93 05/16/2024 Food and Beverage Undisputed 01/23/2026 1145115324 CMS
Mallinckrodt Hospital Products Inc. $14.50 06/14/2024 Food and Beverage Undisputed 01/23/2026 1145115328 CMS
Mallinckrodt Hospital Products Inc. $37.42 08/15/2024 Food and Beverage Undisputed 01/23/2026 1145115332 CMS
Mallinckrodt Hospital Products Inc. $0.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 1145115336 CMS
Regeneron Healthcare Solutions, Inc. $28.88 03/29/2024 Food and Beverage Undisputed 01/23/2026 1114128080 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.